23 24 Penicillin susceptible Staphylococcus aureus (PSSA) may occasionally be 25 encountered as a cause of complicated S. aureus infection, such as endocarditis 26 or bloodstream infections. Clinicians may choose to treat these patients with 27
Introduction 43
Penicillin is commonly used to treat patients with complicated infections with 44 invasive penicillin susceptible Staphylococcus aureus (PSSA) infections.(1) Key 45 advantages of penicillin treatment include a lower MIC distribution compared with 46 other beta-lactam agents active against S. aureus, as well as the ability to achieve 47 higher free non-protein-bound plasma drug concentrations.(1) However, the 48 recently updated American Heart Association guidelines on infective endocarditis 49 do not recommend the use of penicillin for PSSA endocarditis.(2) This decision is 50 primarily based on concerns raised over the ability of laboratory methods to 51 accurately detect certain forms of penicillin resistance in S. aureus; specifically, 52 current evidence indicates that screening methods for the blaZ penicillinase gene 53 are insensitive.(2) 54 55
Two key mechanisms are responsible for resistance to penicillin in staphylococci; 56 the blaZ gene which encodes for penicillinase, a serine beta-lactamase which 57 hydrolyses the β-lactam ring resulting in the production of penicilloic acid, and the 58 mecA gene which encodes for penicillin-binding protein (PBP) 2A. (3, 4) While the 59 presence of mecA can readily and accurately be detected through the use of the 60 cefoxitin disk diffusion test, there are well-recognized difficulties with detection of 61 blaZ. (5) The nitrocefin hydrolysis test, previously a widely used phenotypic 62 method for penicillinase detection amongst S. aureus, has been shown to produce 63 false negative results.(6-10) Molecular methods (including PCR) may be more be 64
accurate, but are typically too expensive and slow compared to the phenotypic 4 methods to be a suitable alternative for routine use. Molecular assays may also be 66 impeded by the nucleotide variations in sequence targets associated with the 67 different blaZ types.(10) At present, both CLSI and EUCAST recommend 68 phenotypic testing via a penicillin disc.(11) By utilizing the penicillin disc method, 69
isolates harbouring blaZ may still appear sensitive according to the zone size, but 70 blaZ presence may be identified by closer inspection of the zone edge, and is 71 indicated by the appearance of a straight edge or cliff. Although being the current 72 recommended method, limited prospective data is available to confirm the validity 73 of penicillin disc detection of blaZ in clinical microbiology laboratories. In fact, 74 experiences at our laboratory suggest that scientists, particularly those 75 infrequently performing the method, struggle to appropriately interpret the zone 76 edges. 77
78
The study was designed to address two aims. The first aim was to use PCR to 79 examine the prevalence of the blaZ beta-lactamase amongst PSSA isolates across 80 3 microbiology laboratories in Queensland. Bacterial DNA was extracted from pure colonies growing on Columbia horse 139 blood agar by the boiling lysis method as follows. Two to three colonies of S. 140 aureus were suspended in 0.5ml of sterile demineralised water and immersed in 141 a water bath at 100 degrees Celsius for 10 minutes. After this, the suspension 142 was centrifuged at 15000 x g for 30 seconds. 50 µl of supernatant was stored at -143 80 degrees Celsius, in preparation for performing nucleic acid amplification 144 testing (NAAT). The overall prevalence rate of blaZ amongst the combined 472 PSSA isolates 174 was 7.3% (n = 34, 95% confidence interval 5.3% -10.1%) according to the blaZ 175 PCR results. This result was similar amongst the 207 isolates from the 176 Townsville Hospital laboratory (prevalence = 6.8%, 95% CI 4.0 -11.0%), the 65 177 isolates from the Gold Coast Hospital laboratory (10.8%, 95% CI 0.8% -13.2%) 178 and the 200 isolates from the PA Hospital laboratory (6.5%, 95% CI 3.8% -179 10.6%). 180
181 Table 1 demonstrates the sensitivity, specificity and predictive values calculated 182
for the penicillin disc test and nitrocefin test for blaZ detection (using the blaz PCR 183 as the gold standard). In comparison to the penicillin disc test, nitrocefin performed 184 poorly at detecting blaZ amongst PSSA isolates. The sensitivity of nitrocefin (15%, 185 95% CI 5 -31%) was lower than the penicillin disc test (97%, 95% CI 85 -100%) 186 for detection of blaZ, with the difference in sensitivity between the penicillin disc 187 test and nitrocefin found to be statistically significant (p < 0.01). Despite the low 188 prevalence rate of blaZ amongst the isolates, a statistically significant difference 189 between the negative predictive value (NPV) of nitrocefin and the penicillin disc In this study, we investigated beta-lactamase detection amongst PSSA isolates 228 in a routine clinical microbiology laboratory following the recent introduction of the 229 penicillin disc test to replace the nitrocefin test. The results of our study, along 230 with other recently reported studies, confirm that the penicillin disc test (using 231 EUCAST methodology) is a reliable predictor of phenotypic activity of blaZ.(8-10) 232
Notably, only 1 isolate that was positive for blaZ by PCR was not detected by the 233 penicillin disc test. This isolate was tested by scientists as part of routine 234 practice and was incorrectly reported as susceptible to penicillin. The isolate was 235 subsequently confirmed as penicillin resistant by the investigators when the test 236 was repeated and the discrepancy was considered to be caused by human error, 237 rather than a problem with the penicillin disc test. Consistent with previous 238 studies, we also found the nitrocefin test to be highly insensitive and re-enforces 239 the decision of our local laboratories to move away from the nitrocefin test as per 240 the updated EUCAST recommendations. (6, 8, 9) 241 242 Overall the prevalence rate of blaZ detected in PSSA from the three laboratories 243 was 7%. This rate is lower than from recently reported SAB data in 2013, in the 244 Australian setting, where 332 (20.4%) isolates initially tested susceptible to 245 penicillin from 1342 episodes of MSSA bacteraemias and beta-lactamase was 246 detected in 69 (20.8%) of the PSSA isolates.(15) These rates support the 247 recommendation made by EUCAST to screen for blaZ amongst PSSA in our 248 region prior to reporting isolates as susceptible to penicillin.(11) Although there 249 are theoretical advantages to using penicillin over other agents for PSSA 250 infections, the use of penicillin for this indication needs to be considered against 251 the capacity of the laboratory to detect blaZ. Importantly, the NPV of the 252 penicillin disc test was 99% when performed by the routine scientists and 100% 253 by the investigators. These high NPVs suggest that if clinicians were to treat 254 patients with penicillin on the basis of a negative penicillin disc test result then 255 the use of use penicillin would be appropriate in at least 99% of cases. In 256 contrast, the significantly lower NPV of the nitrocefin test (94%, p < 0.01) would 257 result in approximately 6% of patients (infected with blaZ-harbouring strains) 258
inappropriately receiving penicillin treatment. Although the positive predictive 259 value (PPV) of the disc test was lower than the nitrocefin method (76% vs 100%), 260 this issue (reporting of false resistance) was not considered a major limitation of 261 the disc test as it would only limit treatment options, rather than leading to 262 incorrect treatment. Also, clinicians may otherwise choose to use flucloxacillin 263 over penicillin regardless of the laboratory reporting penicillin as susceptible. (16) 264 As such, it is our opinion that the potential benefit of the PPV of nitrocefin should 265 not be relied upon when laboratories make a decision in regards to the choice of 266 test for blaZ detection. 267
269
An unusual finding in this study was the identification of 2 subpopulations of 270 14 resistance was able to be identified by induction of sub-populations expressing 272 resistance through prolonged beta-lactam exposure using penicillin discs. A 273 likely explanation for this is the presence of two distinct S. aureus populations 274 (hetero-resistance), one carrying the mecA gene and one without, but with both 275 populations negative for blaZ. It is possible that mecA expression was altered in 276 the absence of blaZ given that mecA induction occurs at a much slower rate than 277 that of blaZ induction, with a recent study demonstrating that expression of mecA 278 relies upon an intact blaZ system. (17) Although our study demonstrated a reliable method for phenotypic detection of 285 beta-lactamase in PSSA isolates there are some limitations. Firstly, we cannot 286 exclude that blaZ variants may not have been detected by the primers and probe 287 used in this study. Similarly, we did not perform any sequencing of the real-time 288 PCR products to confirm the specificity of the assay. In addition, many laboratories 289 only perform beta-lactamase testing in PSSA on isolates from blood culture, or 290 sterile sites, where a long phase of intravenous and/or oral antibiotics may be 291 required. Therefore, for laboratories that perform the test on an ad-hoc basis, 292 accurately discerning the edge of the penicillin disc may prove more challenging. 293
This may explain why the specificity result was shown to be lower for scientists, 294 than for the investigators (93% versus 97%). This point is reinforced in the 295 EUCAST guidelines for clinical breakpoints.(11) A clear instruction is given to err 296 on the side of caution and to report isolates as resistant if the result of the test is 297 not clear to the observer.(11) 298
299
In summary, for clinicians to confidently use penicillin for the treatment of PSSA, 300
we recommend laboratories consider the penicillin disc test over nitrocefin. 301
Notwithstanding this, laboratories performing the penicillin disc test on an ad-hoc 302 basis run the risk of reduced sensitivity and specificity given interpretation of the 303 disc edge may be dependent on the experience of the scientist. 304 305 Table 1 . Sensitivity, specificity, negative and positive predictive value of the penicillin disc test in comparison to nitrocefin. 
